Bayer Healthcare CEO Arthur Higgins
Bayer announced that it is bidding farewell to several of its top executives. The company's CEO for the last 8 years--Werner Wenning (photo)--will depart on September 30, 2010, to be replaced by Thermo Fisher Scientific's CEO Marijn Dekkers (photo). CFO Klaus Kühn (photo) has elected to retire next year and will be replaced by board member Werner Baumann (photo). Bayer Healthcare CEO Arthur Higgins (above) is leaving the company "at his own request." Higgins will leave during the first half of 2010, at which point Dekkers will serve as CEO of Bayer HealthCare during the transition phase.
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
